SC
AERI

Siena Capital’s Aerie Pharmaceuticals AERI Stock Holding History

Siena Capital’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$0 Hold
8
– – ﹤0.01% 275
2022
Q2 		$0 Sell
8
-47
-85% -$331 ﹤0.01% 314
2022
Q1 		$1K Buy
+55
New +$424 ﹤0.01% 297

Other funds holding AERI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Siena Capital's AERI Position: Q3 2022 in Review

Siena Capital held its Aerie Pharmaceuticals (AERI) position steady in Q3 2022 at 8 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #275.

Siena Capital first reported a position in AERI in Q1 2022 and has held it in 3 quarters since. The position peaked at $1K in Q1 2022. 156 funds tracked by Wall St. Rank hold AERI as of Q3 2022.

  • Siena Capital held 8 shares of Aerie Pharmaceuticals worth $0 as of Q3 2022.
  • Siena Capital left its Aerie Pharmaceuticals share count unchanged in Q3 2022.
  • Aerie Pharmaceuticals made up ﹤0.01% of Siena Capital's portfolio in Q3 2022, its #275 holding.
  • Siena Capital first reported a position in Aerie Pharmaceuticals in Q1 2022 and has held it in 3 quarters since.
  • Siena Capital's Aerie Pharmaceuticals position peaked at $1K in Q1 2022.
  • 156 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2022.

Based on Siena Capital's 13F filing for Q3 2022, filed 2 Nov 2022.